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Abstract
Background: Copy number variations (CNVs) are deletions, insertions, duplications, and more
complex variations ranging from 1 kb to sub-microscopic sizes. Recent advances in array
technologies have enabled researchers to identify a number of CNVs from normal individuals.
However, the identification of new CNVs has not yet reached saturation, and more CNVs from
diverse populations remain to be discovered.
Results:  We identified 65 copy number variation regions (CNVRs) in 116 normal Korean
individuals by analyzing Affymetrix 250 K Nsp whole-genome SNP data. Ten of these CNVRs were
novel and not present in the Database of Genomic Variants (DGV). To increase the specificity of
CNV detection, three algorithms, CNAG, dChip and GEMCA, were applied to the data set, and
only those regions recognized at least by two algorithms were identified as CNVs. Most CNVRs
identified in the Korean population were rare (<1%), occurring just once among the 116 individuals.
When CNVs from the Korean population were compared with CNVs from the three HapMap
ethnic groups, African, European, and Asian; our Korean population showed the highest degree of
overlap with the Asian population, as expected. However, the overlap was less than 40%, implying
that more CNVs remain to be discovered from the Asian population as well as from other
populations. Genes in the novel CNVRs from the Korean population were enriched for genes
involved in regulation and development processes.
Conclusion: CNVs are recently-recognized structural variations among individuals, and more
CNVs need to be identified from diverse populations. Until now, CNVs from Asian populations
have been studied less than those from European or American populations. In this regard, our study
of CNVs from the Korean population will contribute to the full cataloguing of structural variation
among diverse human populations.
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Background
Understanding variations in the human genome is the key
to unraveling the phenotypic diversity among individuals
and understanding various human diseases. Genomic var-
iations exist at various levels, from differences in single
nucleotides to microscopic chromosome-level variation
[1]. Copy number variations (CNVs), a new type of
genomic variation that has recently received considerable
attention, are deletions, insertions, duplications, and
more complex variations ranging from 1 kb to submicro-
scopic sizes [1-4]. Recent advances in array technologies
such as BAC arrays, oligonucleotide array CGHs, and
whole-genome SNP arrays, have finally enabled research-
ers to identify this new type of variation, which had gone
unnoticed for a long time [5].
Since Sebat et al. [6] and Iafrate et al. [7] first reported
large-scale CNVs among normal human individuals in
2004, and since then, many researchers have identified
novel CNVs using diverse technical and computational
approaches [8-17]. These reported CNVs are collected and
maintained in a curated database, the database of
genomic variants http://projects.tcag.ca/variation/, which
contains more than 15,000 CNVs obtained from 48 pub-
lications as of April, 2008. However, the discovery of new
CNVs has not yet been saturated, and many challenges
remain for the standardization of CNV discovery [18,19].
The global map of CNVs from the 270 normal individuals
in the HapMap collection is an important advance in the
field, yet genomes from more individuals from diverse
populations should be studied to achieve a full cataloging
of human CNVs [11].
Whole-genome SNP arrays such as Affymetrix 500 K or
Illumina 300 K arrays, which are widely used for whole-
genome association studies, are also useful for CNV dis-
covery since the intensity of the probes can be exploited to
detect CNV gains and losses [20-23]. A few recent studies
successfully utilized whole-genome SNP data from con-
trol populations in North American and European coun-
tries for the detection of novel CNVs [19,22,24,25]. Here,
we report the identification of 10 novel CNVs from 116
normal Korean individuals by analyzing Affymetrix 250
Nsp SNP array data. Our work will be valuable in expand-
ing our knowledge of CNVs across diverse populations
and ethnicities.
Results and discussion
CNVRs from the Korean population
Commonly used algorithms for CNV detection from SNP
arrays can produce widely different results from the same
data because they differ both in the way reference samples
are prepared and in their calling criteria [19,26]. A strin-
gent criterion to select only regions identified by more
than two different algorithms is currently recommended
to increase confidence in the identified CNVs [19]. In this
work, we applied three algorithms, CNAG [21], dChip
[27] and GEMCA [20], to our data set of 116 normal
Korean individuals genotyped using Affymetrix 250 K Nsp
arrays. We identified a total of 65 CNVRs, among which
10 CNVRs (15.4%) were novel and not present in the
Database of Genomic Variants. Many novel CNVs were
likely missed by our approach, but we chose to be con-
servative in our selection of CNVs to reduce false positives.
More than 15.4% of the identified CNVs in the Korean
population would be novel if we consider a recent study,
which showed that most CNV loci are actually smaller
than currently recorded in the Database of Genomic Vari-
ants [28].
As expected, there were significant differences in the num-
bers and positions of CNVs identified by the three meth-
ods (Figure 1). In most cases, the dChip algorithm
identified more CNVs than CNAG and GEMCA. Average
6.7, 3.5 and 2.6 CNVs per individual were found by
dChip, CNAG and GEMCA, respectively (Additional file
1). In total, 772, 403 and 302 CNVs were found by the
dChip, CNAG and GEMCA algorithms. Detailed informa-
tion for each identified CNV is shown in Additional file 2.
A total of 141 CNVs was identified by our criterion of
selecting CNVs represented by more than two algorithms.
When we compared size distribution between 84 dupli-
cated and 57 deleted CNVs (Additional file 2), we found
that duplicated regions had a tendency to be longer than
deleted regions (p < 0.0009664, t-test). When we plotted
each CNV in the genome, we found that most CNVs were
located near the band of each chromosome (Figure 2).
Finally, we defined 65 CNVRs from the 141 CNVs by
merging overlapping CNVs from different individuals
(Additional file 3 and 4).
Size and occurrence of CNVs in the Korean population
The sizes of the 141 CNVs ranged from several kb to sev-
eral megabases (Table 1). The smallest CNV was 15,723
bp, and the largest 2,262,135 bp. Many CNVs were in the
range of 10 kb to 300 kb. We also compared the size dis-
tributions of the CNVs identified by each method. The
smallest, median, and largest CNVs were 998, 153,137
and 2,264,086 bp for the GEMCA algorithm, 1,184,
267,962 and 23,992,731 bp for the CNAG algorithm and
641, 67,372 and 5,035,303 bp for the dChip. In general,
CNVs identified by the dChip algorithm had larger range
than those identified by the GEMCA and CNAG algo-
rithms.
Most CNVs (75%) from the Korean population were rare
(<1%), occurring just once among the 116 individuals
(Table 2). However, a few previously reported CNVs
occurred in a significant proportion of the Korean popu-
lation. For instance, one CNV on chromosome 14 wasBMC Genomics 2008, 9:492 http://www.biomedcentral.com/1471-2164/9/492
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present in 31 individuals. Generally, there were more
CNV gains than losses, and 5 (31%) of the 16 CNVRs had
mixed gains and losses among different individuals.
Among all autosomal chromosomes, CNVs were detected
most frequently on chromosomes 14, 15 and 8.
Comparison by ethnicity
Affymetrix 500 K CEL files from the 270 HapMap individ-
uals were obtained from the Affymetrix web site and ana-
lyzed with the CNAT algorithm to identify CNVs at an
individual level. Also, individual-level CNV data from the
269 HapMap samples obtained by the array CGH method
were downloaded from the copy number variation project
at the Welcome Trust Sanger institute web site http://
www.sanger.ac.uk/humgen/cnv/data/cnv_data/display/.
The 270 individuals were divided into three ethnic groups
– Asian (JPT + CHB), European (CEU), and African (YRI),
and the overlap of CNVs between the Korean population
and each of the three ethnic groups was investigated
(Table 3). Overall, there was a 23–40% overlap in counts
and a 23–79% overlap in actual nucleotides in CNVs
between the Korean population and the three ethnic
groups. The Korean population showed the highest degree
of CNV overlap with the Asian population, as expected,
but the overlap was less than 40%, implying that many
more CNVs remain to be identified from the Asian popu-
lation beyond those identified in the 90 Asian HapMap
individuals.
Novel CNVRs from the Korean population
Among the 10 novel CNVRs identified from the Korean
population, 3 CNVRs contained a total of 5 genes (Addi-
tional file 5). The total length of the novel CNVRs was
1,788,129 bp, or 0.06% of the human genome. The total
Distribution of CNV counts identified using CNAG, dChip and GEMCA algorithms Figure 1
Distribution of CNV counts identified using CNAG, dChip and GEMCA algorithms. Distribution of CNV counts in 
each individual. The Y-axis represents the CNV count and the X-axis represents each individual.BMC Genomics 2008, 9:492 http://www.biomedcentral.com/1471-2164/9/492
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length of the 55 known CNVRs is 14,280,140 bp (0.48%
of the human genome). Twenty-four of these CNVRs con-
tained 52 genes.
Among the three novel CNVRs, we validated two CNVRs
by Q-PCR (Figure 3). One case sample, which had a gain
of two copies in a novel CNVR encompassing SYNPR
gene, showed a 3.59-fold increase in DNA copy number
in comparison to five samples with normal copy number
(Figure 3A). The other validated region was a CNVR con-
taining KRR1 gene, In this case, the case sample, which
had a gain of one copy, showed a 1.86-fold increase in
DNA copy number in comparison to five samples with
normal copy number (Figure 3B).
We analyzed the functional enrichment of genes con-
tained in the CNVRs from the Korean population using
Distribution and frequencies of CNVs identified in Korean population in the human genome Figure 2
Distribution and frequencies of CNVs identified in Korean population in the human genome. The blue triangle 
indicates gains and the red inverted triangle indicates losses, respectively.
Table 1: Distribution of CNV sizes identified in the Korean 
population
Size (bp) Novel CNV Known CNV Sum
10 K–100 K 3 33 36
100 K–200 K 3 58 61
200 K–300 K 3 8 11
300 K–400 K 0 8 8
400 K–500 K 1 4 5
500 K–1 M 0 7 7
1 M–10 M 0 13 13
Total 10 131 141
Table 2: Occurrence of CNVs among the Korean population
Occurrence Novel CNV Known CNV Sum
11 0 3 9 4 9
20 7 7
30 2 2
40 2 2
50 1 1
60 0 0
70 2 2
80 0 0
90 0 0
10 0 0 0
11–20 0 1 1
21–30 0 0 0
31–40 0 1 1
Total 10 55 65BMC Genomics 2008, 9:492 http://www.biomedcentral.com/1471-2164/9/492
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the GOstat tool (Table 4 and 5) [29]. The novel CNVRs
were enriched with genes involved in regulation and
development processes (Table 4). Genes in the previously
known CNVRs were mainly related to processes such as
cell adhesion, multicellular, development, and regulation
of gene expression (Table 5). Our results are in agreement
with Nguyen et al.'s work, which showed the over-repre-
sentation of secreted, cell adhesion, and immunity-related
proteins in CNV-associated genes [30].
The fact that 15% (10/65) of CNVs in the Korean popula-
tion were novel implies that current CNV discovery has
not yet plateaued, and that the genomes of more individ-
uals should be examined to fully understand CNVs in the
general population. Until recently, CNV studies have
mainly focused on populations in North America and
Europe [19,25]. More individuals from other continents,
such as Asia, Africa, and South America, need to be stud-
ied to enrich our understanding of the diversity of CNVs
in the human population. We stress that the Korean pop-
ulation had less than a 40% overlap in CNVRs with the 90
Asian HapMap individuals, which suggests that more
individuals should be studied to fully represent the pat-
tern of CNVs among East Asian populations. In this
regard, our work on 116 Korean individuals will be a use-
Table 3: Overlap between CNVs from the Korean population and CNVs from the 270 HapMap individuals
Ethnicity HAP* CNV 
count
HAP CNVR 
count
HAP CNV 
size (bp)
KOR# unique 
count
KOR-HAP 
overlap count
KOR-HAP 
overlap size 
(bp)
KOR-HAP 
overlap count 
percent
KOR-HAP 
overlap size 
percent
A. Affymetrix 500 K
CHB+JPT 1,957 593 394,995,510 39 26 7,326,741 40.00% 45.60%
CEU 1,700 305 231,661,002 50 15 3,634,120 23.08% 22.62%
YRI 1,627 318 236,857,444 45 20 4,576,087 30.77% 28.48%
B. WGTP
CHB+JPT 5,753 990 361,340,796 42 23 12,679,720 35.38% 78.91%
CEU 5,597 970 358,358,246 50 15 6,486,626 23.08% 40.37%
YRI 7,280 469 170,541,572 46 19 4,482,724 29.23% 27.90%
*HAP: HapMap individuals.
#KOR: Korean population
Validation of two novel CNVRs by Q-PCR Figure 3
Validation of two novel CNVRs by Q-PCR. (A) SYNPR, (B) KRR1. For each gene, one case (with a CNVR) and five nor-
mal controls were compared by Q-PCR. The mean of five control samples was arbitrarily set to 1 and each sample was com-
pared to the mean value. Each bar and error bar represents a mean and standard deviation of relative expression values from 
triplicate experiments.
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ful resource for better understanding the diverse variation
in the human genome.
Conclusion
Recent studies have shown that CNVs are as important as
single nucleotide polymorphisms (SNPs) or microscopic
variations. Many studies have reported the identification
of novel CNVs, but more CNVs from diverse populations
should be identified until we have a full catalogue of the
structural variations among human populations. Until
now, the CNVs of Asian populations have not been as
thoroughly studied as those of European or American
populations, and in this regard our study of CNVs from
the Korean population will contribute to the full catalogu-
ing of structural variations among diverse human popula-
tions.
Methods
DNA samples
Blood specimens were obtained from normal, healthy
subjects who visited the Korean Institute of Oriental Med-
icine (KIOM) and collaborative hospitals. The internal
review board at KIOM approved study protocols and
informed consent was obtained from all enrolled study
subjects. Genomic DNA was extracted from blood sam-
ples using the QIAamp DNA Blood Maxi Kit (Qiagen,
Valencia, CA) according to the manufacturer's instruction.
DNA concentration and purity were determined using the
NanoDrop DN-1000 spectrophotometer (NanoDrop
Technologies, Rockland, DE).
Table 4: Functional annotation of novel CNVs from the Korean population
GO id Group count Total count P-value GO terms
GO:0045995 1 8 0.033 regulation of embryonic development
GO:0050679 1 18 0.0333 positive regulation of epithelial cell proliferation
GO:0050678 1 30 0.0333 regulation of epithelial cell proliferation
GO:0050673 1 33 0.0333 epithelial cell proliferation
GO:0030334 1 60 0.0333 regulation of cell migration
GO:0030155 1 66 0.0333 regulation of cell adhesion
GO:0051270 1 69 0.0333 regulation of cell motility
GO:0040012 1 72 0.0333 regulation of locomotion
GO:0040011 1 73 0.0333 locomotion
GO:0016477 1 233 0.0738 cell migration
GO:0008284 1 233 0.0738 positive regulation of cell proliferation
GO:0009790 1 235 0.0738 embryonic development
GO:0050793 1 236 0.0738 regulation of developmental process
Table 5: Functional annotation of known CNVs from the Korean population
GO id Group count Total count P-value GO terms
GO:0007565 5 81 7.62E-06 female pregnancy
GO:0007608 7 540 0.000303 sensory perception of smell
GO:0007606 7 584 0.000336 sensory perception of chemical stimulus
GO:0022414 5 305 0.00128 reproductive process
GO:0051704 5 333 0.00156 multi-organism process
GO:0007600 7 950 0.00365 sensory perception
GO:0007165 15 5142 0.0117 signal transduction
GO:0007166 10 2433 0.0117 cell surface receptor linked signal transduction
GO:0050877 7 1269 0.0134 neurological system process
GO:0007186 8 1677 0.0134 G-protein coupled receptor protein signaling pathway
GO:0007154 15 5560 0.0237 cell communication
GO:0006433 1 2 0.0264 prolyl-tRNA aminoacylation
GO:0003008 7 1539 0.0286 system process
GO:0017000 1 3 0.0339 antibiotic biosynthetic process
GO:0016999 1 4 0.0421 antibiotic metabolic process
GO:0009649 1 5 0.0493 entrainment of circadian clock
GO:0007185 1 6 0.0498 transmembrane receptor protein tyrosine phosphatase signaling pathway
GO:0006426 1 6 0.0498 glycyl-tRNA aminoacylation
GO:0017144 1 6 0.0498 drug metabolic processBMC Genomics 2008, 9:492 http://www.biomedcentral.com/1471-2164/9/492
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Affymetrix GeneChip Nsp 250 K Mapping Array data
The 250 K Nsp mapping assay was performed according to
the manufacturer's protocol. Briefly, DNA (250 ng) was
digested with NspI (NEB, MA) and then ligated with an
NspI linker supplied by Affymetrix. The ligated DNA was
diluted four-fold and PCR-amplified using a PCR primer
complementary to the linker DNA. The PCR products
were purified using a DNA Amplification Clean-Up Kit
(Clontech, CA) and 90 μg of the PCR products were frag-
mented by DNase I treatment. The fragmented DNA was
labelled using 0.86 mM GeneChip DNA labelling reagents
(Affymetrix) and 1.5 U/μl terminal deoxy-nucleotidyl
transferase (TdT) for 4 hr at 37°C, while the remaining 4.5
μl was examined on 4% TBE agarose gel to confirm that
average DNA fragment size was < 180 bp. Hybridization
and subsequent steps were performed according to the
manufacturer's instructions. Hybridization experiments
that passed the genotyping call rate over 93% by the
dynamic model algorithm were used in the subsequent
analysis to reduce false positive predictions arising from
low quality genotyping data.
Copy number analysis using CNAG, dChip and GEMCA
Three algorithms, CNAG (version 2.0), GEMCA (avail-
able at http://www2.genome.rcast.u-tokyo.ac.jp/CNV/
gemca_details.html) and dChip, were used to infer
copy numbers from 250 K Nsp SNP array data.
A reference data set of 48 normal individuals (obtained
from the Affymetrix website) was used in the non-paired
reference analysis with default parameters and CNVs
inferred as more than two consecutive SNPs in CNAG
analysis. In the GEMCA analysis, a reference data set of 10
normal individuals was used in the non-paired reference
analysis and the default parameters were used. The
boundary of CNVs was determined using 90% density
borders [20]. Analysis with dChip was normalized at the
probe intensity level with an invariant set normalization
method [27]. A signal value was calculated for each SNP
using an average model method (PM/MM difference).
From the raw copy numbers, the inferred copy number
was estimated by using HMM (Hidden Markov model)
and 10% of sample trimmed options and CNVs were
inferred as more than two consecutive SNPs. Finally, for
each individual, CNVs were defined as a region identified
by more than two algorithms (overlap rate >= 50%, length
>= 1000 bp). This strategy is likely to increase a confi-
dence in the detected CNVs although many novel CNVs
may be missed [19]. Considering the current lack of stand-
ards in CNV discovery methods, we think that a more
stringent approach like ours is appropriate. NCBI genome
build 36 (hg18) was used to map each CNV to its genomic
position.
Comparison of Korean CNVs with those of 270 HapMap 
individuals
CEL files for the 270 HapMap individuals were down-
loaded from the Affymetrix web site. For copy number
analysis of the 270 HapMap samples, the same reference
set of 48 samples was used in the CNAT analysis. CNV
data for each of the 269 HapMap individuals investigated
using the whole genome TilePath (WGTP) array was
downloaded from the CNV Project web site at the Wel-
come Trust Sanger Institute http://www.sanger.ac.uk/
humgen/cnv/[11].
Determination of novel CNVRs and functional annotation 
analysis
CNVs identified in our Korean population were compared
with 11,966 CNVs in the Database of Genomic Variants
(downloaded as of Feb. 2008). The GOstat web service
was used for gene ontology (GO) term analysis to study
the enrichment of GO terms in the known and novel
CNVs [29]. This analysis was performed with the default
option for biological processes and the GO term candi-
dates were ordered by p-value.
Quantitative-PCR (Q-PCR) for CNVs validation
Two selected novel CNVs were validated by Q-PCR. Q-
PCR was done in 20 μl with the following components:
7.0 μl of molecular biology grade water (Hyclone, US), 10
μl of 2 × SYBR Green Premix EX Taq solution, 0.5 μl of for-
ward and reverse primers (10 pmol/μl each) and 2 μl tem-
plate DNA (1 ng/ml). Primer sequences were 5'-
AGCCAGCTATCAGGTGAGGA-3' (SYNPR-forward), 5'-
ACTTGTCTAAGCCCCTGCAA-3' (SYNPR-reverse), 5'-
GAGTGGGCTTTGTGGTGAAT-3' (KRR1-forward) and 5'-
TGTGCTGGGCATATTAGTGG-3' (KRR1-reverse). Q-PCR
was conducted using CFX96 (Bio-Rad Laboratories, US)
with the following cycling condition: initial denaturation
at 95°C for 3 min followed by 45 cycles of 95°C for 10 s,
60°C for 20 s and and 72°C for 20 s. The relative quanti-
fication in each sample was determined.
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